What the six lenses say about JBCHEPHARM — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How JBCHEPHARM’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.0pp | +6.2pp | +7.8pp | +22.3pp | +36.1pp | +56.9pp |
Nifty 500 Broad-market baseline | -0.4pp | +6.1pp | +7.2pp | +18.6pp | +31.1pp | +53.1pp |
Sector Own-sector index | — | — | +4.8pp | +6.1pp | +16.7pp | +35.2pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
JBCHEPHARM daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
JBCHEPHARM ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,004 | 1,001 | 963 | 949 | 1,094 | 1,085 | 1,065 | 904 |
| ↳ change QoQ | — | -0.4% | -3.7% | -1.5% | +15.3% | -0.8% | -1.8% | -15.1% |
| EBITDA (₹cr) | 286 | 280 | 263 | 226 | 301 | 310 | 296 | 201 |
| EBITDA margin | 28.5% | 28.0% | 27.3% | 23.8% | 27.5% | 28.6% | 27.8% | 22.2% |
| PAT (₹cr) | 177 | 175 | 162 | 146 | 202 | 208 | 198 | 101 |
| ↳ change QoQ | — | -1.3% | -6.9% | -10.1% | +38.4% | +3.0% | -4.8% | -49.0% |
| Net margin | 17.6% | 17.4% | 16.9% | 15.4% | 18.5% | 19.2% | 18.6% | 11.2% |
| EPS (₹) | 11.39 | 11.24 | 10.46 | 9.36 | 12.97 | 13.27 | 12.63 | 6.31 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A dividend declaration — a cash return to shareholders.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding JBCHEPHARM (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Kotak Midcap Reg Gr | 1.64% | 67,611 | |
| Axis Midcap Gr | 0.65% | 32,852 | |
| Axis ELSS Tax Saver Fd Gr | 0.76% | 31,023 | |
| Axis Small Cap Fund Reg Gr | 2.32% | 27,840 | |
| Kotak Small Cap Reg Gr | 0.88% | 18,691 | |
| Edelweiss Mid Cap Gr | 0.58% | 16,849 | |
| Canara Robeco Small Cap Reg Gr | 2.23% | 13,967 | |
| Canara Robeco Flexi Cap Reg Gr | 0.97% | 13,328 | |
| Axis Multicap Reg Gr | 0.74% | 9,938 | |
| Nippon India Flexi Cap Reg Gr | 1.27% | 9,590 |
ETFs holding JBCHEPHARM (9)